Product
AIV001
2 clinical trials
3 indications
Indication
Superficial Basal Cell CarcinomaIndication
Basal Cell CarcinomaIndication
KeloidClinical trial
An Exploratory Study to Evaluate the Safety and Efficacy of AIV001 Intradermally Administered in Subjects With Biopsy-confirmed Basal Cell CarcinomaStatus: Completed, Estimated PCD: 2023-06-20
Clinical trial
An Exploratory Study to Evaluate the Safety and Efficacy of Intradermal Administration of AIV001 Aqueous Suspension on Scar Formation and Keloid Recurrence Following KeloidectomyStatus: Completed, Estimated PCD: 2022-12-15